Company Overview
About Ginkgo Bioworks
Ginkgo Bioworks is a synthetic biology platform company that provides cell programming services to the agricultural, pharmaceutical, food, and industrial chemicals industries, helping customers design and manufacture biological products using engineered microorganisms. Founded in 2008 by MIT researchers and headquartered in Boston, Ginkgo went public via SPAC merger in September 2021 at a $15 billion valuation — one of the largest biotech-related SPAC transactions ever.
Business Model & Competitive Advantage
Ginkgo's platform combines automated biology labs (called Foundries), proprietary genetic parts libraries (the Codebase), and data analysis to dramatically reduce the cost and time to engineer cells for industrial applications. Customers pay Ginkgo to design strains that produce target compounds — enzymes, proteins, novel molecules — using a platform fee plus royalty model. The company has collaborated with Bayer (agriculture), Sumitomo Chemical, Ginkgo Crop Protection, and defense agencies on biological manufacturing programs.
Competitive Landscape 2025–2026
In 2025, Ginkgo has undergone significant restructuring after its SPAC valuation proved unsustainably high relative to revenue growth. The company announced major layoffs of over 50% of its workforce in 2023-2024 and sold or wound down several subsidiary businesses to reduce cash burn. Revenue has been concentrated in government biosecurity contracts (Ginkgo Biosecurity) rather than commercial synthetic biology, raising questions about the commercial viability of its original platform vision. Ginkgo's 2025-2026 survival strategy focuses on right-sizing costs, expanding government biosecurity revenue, and identifying the core platform capabilities worth preserving.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Ginkgo Bioworks is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Compare Ginkgo Bioworks with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ginkgo Bioworks? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ginkgo Bioworks Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ginkgo Bioworks vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →